click below
click below
Normal Size Small Size show me how
CNS 1
| Pharmacological category | Generic | Brand | Common Indication | Key Side effects | US boxed warnings | Other notes |
|---|---|---|---|---|---|---|
| Alpha2 antagonist | mirtazapine (PO) | Remeron | MDD | drowsiness, weight gain, xerostomia, increased appetite, constipation | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | n/a |
| Norepinephrine- dopamine reuptake inhibitor | bupropion (PO) | Wellbutrin SR, Wellbutrin XL | MDD | tachycardia, headache, agitation, dizziness, insomnia, weight loss, xerostomia | increased risk of suicidal thinking and behavior in children, adolescents, and young adults; serious neuropsychiatric reactions have occurred | use may increase risk of seizures (CI in patients with seizure disorders and/or eating disorders) |
| Selective norepinephrine reuptake inhibitor | atomoxetine (PO) | Strattera | ADHD | hypertension, tachycardia, headache, xerostomia, nausea, vomiting, constipation, decreased appetite, insomnia | increased risk of suicidal ideation in children or adolescents | CI within 14 days of MAOI |
| Serotonin- norepinephrine reuptake inhibitor (SNRI) | desvenlafaxine (PO) | Pristiq | MDD | headache, xerostomia, nausea, vomiting, constipation, decreased appetite, insomnia. diaphoresis, hypertension, sexual dysfunction | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| Serotonin- norepinephrine reuptake inhibitor (SNRI) | duloxetine (PO) | Cymbalta | MDD, neuropathic pain | headache, xerostomia, nausea, vomiting, constipation, decreased appetite, insomnia. diaphoresis, hypertension, sexual dysfunction | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| Serotonin- norepinephrine reuptake inhibitor (SNRI) | venlafaxine (PO) | Effexor XR | MDD | headache, xerostomia, nausea, vomiting, constipation, decreased appetite, insomnia. diaphoresis, hypertension, sexual dysfunction | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| Selective serotonin reuptake inhibitor (SSRI) | citalopram (PO) | Celexa | MDD | drowsiness, insomnia, nausea, vomiting, xerostomia, sexual dysfunction, headache, diaphoresis | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly (all except fluoxetine) |
| Selective serotonin reuptake inhibitor (SSRI) | fluoxetine (PO) | Prozac | MDD | drowsiness, insomnia, nausea, vomiting, xerostomia, sexual dysfunction, headache, diaphoresis | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly (all except fluoxetine) |
| Selective serotonin reuptake inhibitor (SSRI) | escitalopram (PO) | Lexapro | MDD | drowsiness, insomnia, nausea, vomiting, xerostomia, sexual dysfunction, headache, diaphoresis | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly (all except fluoxetine) |
| Selective serotonin reuptake inhibitor (SSRI) | paroxetine (PO) | Paxil | MDD | drowsiness, insomnia, nausea, vomiting, xerostomia, sexual dysfunction, headache, diaphoresis | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly (all except fluoxetine) |
| Selective serotonin reuptake inhibitor (SSRI) | sertraline (PO) | Zoloft | MDD | drowsiness, insomnia, nausea, vomiting, xerostomia, sexual dysfunction, headache, diaphoresis | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly (all except fluoxetine) |
| Serotonin reuptake inhibitor | trazodone (PO) | Desyrel | Insomnia, MDD | sedation, headache, dizziness, xerostomia, nausea, priapism | increased risk of suicidal thinking and behavior in children, adolescents and young adults | n/a |
| Tricyclic antidepressant (TCA) | amitriptyline (PO) | Elavil | MDD, diabetic neuropathy, migraine prophylaxis | dizziness, drowsiness, orthostatic hypotension, sexual dysfunction, xerostomia, blurred vision, constipation | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| Tricyclic antidepressant (TCA) | nortriptyline (PO) | Pamelor | MDD, diabetic neuropathy, migraine prophylaxis | dizziness, drowsiness, orthostatic hypotension, sexual dysfunction, xerostomia, blurred vision, constipation | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| Tricyclic antidepressant (TCA) | doxepin (PO) | Silenor | Insomnia | somnolence, sedation, nausea | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |